H. Park et al. / Tetrahedron 61 (2005) 6352–6367
6361
1H), 4.19–4.09 (m, 2H), 3.66–3.36 (m, 2H), 1.71 (s, 3H,
CH3CO); 13C NMR (101 MHz, CDCl3) d 170.1, 137.6,
137.5, 137.3, 136.7, 136.7, 129.5, 129.1, 129.0, 128.8,
128.8, 128.6, 128.3, 127.0, 102.5, 96.8, 87.4, 82.8, 77.6,
70.8, 70.0, 69.8, 69.5, 58.5, 49.5; 31P NMR (101 MHz,
CDCl3) d 144.0 (s, 1P).
5.2.9. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-a-
D-glucopyranoside cyclic (S)-[1,10-binaphthalene]-2,20-
diyl phosphite (10B). Procedure C. Quantitative yield; H
1
NMR (300 MHz, CDCl3) d 7.94–7.14 (m, 22H, aromatic),
5.67 (s, 1H, benzylic), 5.55 (d, JZ9.1 Hz, 1H, NH), 4.97 (d,
JZ3.7 Hz, 1H, H-1), 4.73 and 4.48 (AB, JZ11.7 Hz, 2H,
OCH2Ph), 4.52 (q, JZ9.7 Hz, 1H, H-3), 4.38–4.25 (m, 2H,
H-2, H-6eq), 3.99 (td, JZ9.9, 4.7 Hz, 1H, H-5), 3.85 (t, JZ
10.2 Hz, 1H, H-6ax), 3.77 (t, JZ9.3 Hz, 1H, H-4), 1.78 (s,
3H, CH3CO); 31P NMR (101 MHz, CDCl3) d 150.9 (s, 1P).
5.2.13. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-
a-D-allopyranoside cyclic (S,S)-1,2-diphenylethylene
phosphite (11D). Procedure C. 83% Yield; 1H NMR
(250 MHz, CDCl3) d 7.45–6.83 (m, 20H, aromatic), 6.06 (d,
JZ9.5 Hz, 1H, NH), 5.54 (s, 1H, benzylic), 4.93 (d, JZ
9.2 Hz, 1H), 4.80–4.68 (m, 3H), 4.52 and 4.27 (AB, JZ
11.7 Hz, 2H, OCH2Ph), 4.37–4.15 (m, 3H), 3.72–3.64 (m,
2H), 1.82 (s, 3H, CH3CO); 13C NMR (101 MHz, CDCl3) d
170.2, 138.1, 137.6, 137.5, 137.0, 136.9, 129.6, 129.0,
128.9, 128.9, 128.7, 128.6, 128.5, 128.3, 127.4, 127.3,
126.9, 102.7, 97.7, 87.3, 83.7, 71.5, 71.1, 70.9, 69.7, 66.3,
58.8, 49.7; 31P NMR (101 MHz, CDCl3) d 144.9 (s, 1P).
5.2.10. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-
a-D-allopyranoside cyclic (R)-[1,10-binaphthalene]-2,20-
diyl phosphite (11A). Procedure C. 80% Yield; H NMR
1
(300 MHz, CDCl3) d 7.98–6.86 (m, 22H, aromatic), 5.78 (d,
JZ9.5 Hz, 1H, NH), 5.71 (s, 1H, benzylic), 4.86 (dt, JZ9.5,
3.0 Hz, 1H, H-2), 4.78 (d, JZ4.5 Hz, 1H, H-1), 4.58 and
4.30 (AB, JZ12.2 Hz, 2H, OCH2Ph), 4.45–4.27 (m, 3H,
H-3, H-5, H-6eq), 3.84–3.75 (m, 2H, H-4, H-6ax), 1.67 (s,
3H, CH3CO); 31P NMR (101 MHz, CDCl3) d 156.0 (s, 1P).
5.2.14. Benzyl 4,6-O-benzylidene-2-deoxy-3-O-(di-3,5-
xylylphosphino)-2-(2,2,2-trifluoroacetamido)-a-D-allo-
pyranoside (12). Procedure B. 81% Yield; 1H NMR
(400 MHz, CDCl3) d 7.29–6.90 (m, 16H, aromatic), 6.46
(d, JZ9.4 Hz, 1H, NH), 5.47 (s, 1H, benzylic), 4.82 (d, JZ
4.3 Hz, 1H, H-1), 4.80 and 4.51 (AB, JZ12.0 Hz, 2H,
OCH2Ph), 4.53 (m, 1H, H-3), 4.41 (td, JZ10.2, 5.1 Hz, 1H,
H-5), 4.26 (dt, JZ9.5, 3.9 Hz, 1H, H-2), 4.19 (dd, JZ10.3,
5.2 Hz, 1H, H-6eq), 3.68–3.64 (m, 2H, H-4, H-6ax), 2.12 (s,
6H, 2Me), 2.08 (s, 6H, 2Me); 13C NMR (101 MHz, CDCl3)
d 145.1, 144.6, 141.0, 140.1, 139.8, 139.6, 134.4, 133.3,
131.5, 131.3, 130.9, 130.8, 130.7, 130.6, 130.4, 130.1,
129.9, 129.0, 104.7, 98.2, 80.8, 72.9, 71.8, 68.5, 61.0, 52.3,
23.9, 23.8; 31P NMR (162 MHz, CDCl3) d 126.1 (s, 1P).
5.2.11. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-
a-D-allopyranoside cyclic (S)-[1,10-binaphthalene]-2,20-
diyl phosphite (11B). Procedure C. 88% Yield; H NMR
1
(250 MHz, CDCl3) d 7.82–6.88 (m, 22H, aromatic), 6.09 (d,
JZ9.4 Hz, 1H, NH), 5.54 (s, 1H, benzylic), 4.79 (dt, JZ8.7,
2.9 Hz, 1H, H-2), 4.72 (d, JZ4.4 Hz, 1H, H-1), 4.43 and
4.24 (AB, JZ12.5 Hz, 2H, OCH2Ph), 4.34 (m, 1H, H-3),
4.08–3.98 (m, 2H, H-5, H-6eq), 3.64–3.57 (m, 2H, H-4,
H-6ax), 1.97 (s, 3H, CH3CO); 13C NMR (71.6 MHz,
CDCl3) d 169.3, 148.1, 147.4, 137.4, 137.3, 132.8, 131.5,
130.9, 130.3, 129.3, 129.2, 128.4, 128.3, 128.3, 128.2,
127.5, 127.2, 127.1, 127.0, 126.6, 126.3, 126.2, 126.0,
125.0, 124.9, 121.9, 121.9, 121.5, 101.6, 96.4, 77.2, 71.6,
71.4, 69.8, 68.9, 57.7, 48.9, 48.9; 31P NMR (101 MHz,
CDCl3) d 150.6 (s, 1P).
5.2.15. Benzyl 2-benzamido-4,6-O-benzylidene-2-deoxy-
3-O-(di-3,5-xylylphosphino)-a-D-allopyranoside (13).
Procedure B. 77% Yield; H NMR (250 MHz, CDCl3) d
1
7.34–6.82 (m, 21H, aromatic), 6.35 (d, JZ9.2 Hz, 1H, NH),
5.45 (s, 1H, benzylic), 4.89 (d, JZ4.2 Hz, 1H, H-1), 4.70
and 4.48 (AB, JZ12.0 Hz, 2H, OCH2Ph), 4.61–4.41 (m,
3H, H-2, H-3, H-5), 4.17 (dd, JZ10.2, 5.2 Hz, 1H, H-6eq),
3.72–3.61 (m, 2H, H-4, H-6ax), 2.07 (s, 6H, 2Me), 1.99 (s,
6H, 2Me); 13C NMR (101 MHz, CDCl3) d 166.8, 144.0,
142.9, 138.8, 138.1, 138.9, 137.6, 133.7, 131.9, 131.8,
130.9, 129.1, 128.9, 128.7, 128.6, 128.4, 128.3, 128.2,
128.1, 127.8, 127.5, 127.2, 126.8, 102.5, 97.3, 78.8, 70.7,
70.7, 66.3, 58.9, 50.3, 21.7, 21.6; 31P NMR (101 MHz,
5.2.12. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-
a-D-allopyranoside cyclic (R,R)-1,2-diphenylethylene
phosphite (11C). Procedure C. 84% Yield; 1H NMR
(250 MHz, CDCl3) d 7.36–7.03 (m, 20H, aromatic), 5.99 (d,
JZ9.45 Hz, 1H, NH), 5.47 (s, 1H, benzylic), 5.19 (d, JZ
9.6 Hz, 1H), 4.82 (d, JZ4.5 Hz, 1H), 4.76 and 4.54 (AB,
JZ12.2 Hz, 2H, OCH2Ph), 4.68–4.63 (m, 2H), 4.35 (m,